SCHEMBL426330

SCHEMBL426330

CCC=COC(=O)CCC(=O)OC=CCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.41
NR1I2 O75469 2/20 0.41
PTGS2 P35354 2/20 0.41
PGR P06401 1/20 0.41
PDE4D Q08499 1/20 0.41
ALDH1A1 P00352 9/20 0.40
OXER1 Q8TDS5 4/20 0.40
CYP19A1 P11511 4/20 0.40
PPARG P37231 3/20 0.40
MAPT P10636 3/20 0.40
RXRA P19793 2/20 0.40
FFAR1 O14842 2/20 0.40
TSHR P16473 2/20 0.39
CYP3A4 P08684 2/20 0.39
ALOX15 P16050 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
F7 P08709 3/20 0.38
F3 P13726 3/20 0.38
PTGS1 P23219 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL848823 1.00 ADORA3 (0.41) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL848824 0.91 ALDH1A1 (0.48) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL2436338 0.91 ALDH1A1 (0.48) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL2436339 0.91 ALDH1A1 (0.48) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL424129 0.91 ALDH1A1 (0.49) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL3455390 0.89 NR1I2 (0.56) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL3455391 0.89 NR1I2 (0.56) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL422419 0.89 ALDH1A1 (0.51) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL3899428 0.89 ADORA3 (0.38) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL3904286 0.87 ADORA3 (0.37) ADORA3NR1I2PTGS2PGRPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020231175-A1 ABSORBENT STRUCTURE, AND ABSORBENT PAD INCLUDING SAME 김병용 2020-11-19 WO claimed
US-8597604-B2 Tricalcium phosphates, their composites, implants incorporating them, and methods for their production PIONEER SURGICAL TECHNOLOGY, INC. (US) 2013-12-03 US claimed
US-20110318402-A1 TRICALCIUM PHOSPHATES, THEIR COMPOSITES, IMPLANTS INCORPORATING THEM, AND METHODS FOR THEIR PRODUCTION ANGSTROM MEDICA (US) 2011-12-29 US claimed
US-8029755-B2 particulate tricalcium phosphate (TCP) having an average particle size of about 5 mu m or less, an average crystal size of about 250 nm or less and a surface area of about 20 m2/g or greater; ANGSTROM MEDICA (US) 2011-10-04 US claimed
JP-2007503849-A 2007-03-01 JP claimed
EP-1660036-A2 TRICALCIUM PHOSPHATES, THEIR COMPOSITES, IMPLANTS INCORPORATING THEM, AND METHODS FOR THEIR PRODUCTION Angstrom Medica, Inc. (US) 2006-05-31 EP claimed
WO-2005032456-A2 TRICALCIUM PHOSPHATES, THEIR COMPOSITES, IMPLANTS INCORPORATING THEM, AND METHODS FOR THEIR PRODUCTION ANGSTROM MEDICA, INC (US) 2005-04-14 WO claimed
US-20050031704-A1 Tricalcium phosphates, their composites, implants incorporating them, and method for their production ANGSTROM MEDICA (US) 2005-02-10 US claimed
WO-2024147693-A1 BRANCHED POLYLACTIC ACID POLYMER AND METHOD FOR PREPARING SAME 주식회사 엘지화학 2024-07-11 WO disclosed
WO-2021025496-A2 HYGIENIC ABSORBENT POUCH, HYGIENIC ABSORBENT PRODUCT, AND METHOD OF USING SAME 김병용 2021-02-11 WO disclosed
WO-2020231175-A1 ABSORBENT STRUCTURE, AND ABSORBENT PAD INCLUDING SAME 김병용 2020-11-19 WO disclosed
US-10799610-B2 Cement products and methods of making and using the same PIONEER SURGICAL TECHNOLOGY, INC. (US) 2020-10-13 US disclosed
US-10413632-B2 Cement products and methods of making and using the same PIONEER SURGICAL TECHNOLOGY, INC. (US) 2019-09-17 US disclosed
US-20180264165-A1 CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME MIDCAP FINANCIAL TRUST 2018-09-20 US disclosed
WO-2005032456-A2 TRICALCIUM PHOSPHATES, THEIR COMPOSITES, IMPLANTS INCORPORATING THEM, AND METHODS FOR THEIR PRODUCTION ANGSTROM MEDICA, INC (US) 2005-04-14 WO disclosed
US-20050031704-A1 Tricalcium phosphates, their composites, implants incorporating them, and method for their production ANGSTROM MEDICA (US) 2005-02-10 US disclosed
EP-1502932-A1 RESIN COMPOSITION Sony Corporation (JP) 2005-02-02 EP disclosed
US-20030002216-A1 Magnetic tape cassettes and processes for producing them FUJI PHOTO FILM CO., LTD. 2003-01-02 US disclosed
JP-2002339341-A BIODEGRADABLE MATERIAL FOR AGRICULTURE-AND-FORESTRY CIVIL ENGINEERING AND GROUND REINFORCING CLOTH USING THE SAME HEISEI POLYMER CO LTD 2002-11-27 JP disclosed
EP-1162221-A1 POLYURETHANE RESIN WITH DEGRADABILITY Mitsui Chemicals, Inc. (JP) 2001-12-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180264165-A1 CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME BHMT2, SHMT1, BHMT ADORA3 2513/4885NR1I2 3454/4885PTGS2 677/4885
US-10799610-B2 Cement products and methods of making and using the same BHMT2, SHMT1, BHMT ADORA3 2513/4885NR1I2 3454/4885PTGS2 677/4885
US-10413632-B2 Cement products and methods of making and using the same BHMT2, SHMT1, BHMT ADORA3 2513/4885NR1I2 3454/4885PTGS2 677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.